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Sodium measurements are often performed during the preoperative 
anaesthetic workup in surgical patients.[1] Preoperative dysnatraemia 
(a preoperative serum sodium measurement outside the normal 
range of 135 - 144 mEq/L) is a common electrolyte imbalance in non-
cardiac surgical patients.[2,3] An estimated 40% of non-cardiac surgi-
cal patients in the European Surgical Outcomes Study (EuSOS) were 
reported to have had an abnormal preoperative sodium measure-
ment.[1]
The clinical relevance of preoperative dysnatraemia is gaining 
acknowledgement. A study by Hu et al.[4] suggests that not only 
is dysnatraemia common in hospitalised patients, but it is also 
independently associated with poor outcomes. In this study, the 
hyponatraemia group showed that 46.3% developed hyponatraemia 
on admission and 53.7% after 24 hours of hospitalisation, while 
65.8% had persistent hyponatraemia. In the hypernatraemia group, 
patients were divided into community-acquired (50.4%) and hospi-
tal-acquired (49.6%) hypernatraemia, with 49.1% having persistent 
hypernatraemia. Mc Causland et al.[5] also demonstrated a higher 
risk of mortality in orthopaedic surgical patients with abnormal 
preoperative serum sodium measurements (hazard ratio (HR) 2.47, 
95% confi dence interval (CI) 1.33 - 4.59 for moderate/severe hypona-
traemia; HR 1.80, 95% CI 1.21 - 2.66 for mild hyponatraemia; and 
HR 2.99, 95% CI 1.79 - 4.98 for hypernatraemia).[5]
Although a subanalysis of patient data from EuSOS found mode-
rate to severe preoperative hypernatraemia to be associated with an 
increased risk of postoperative mortality, a statistically significant 
association between preoperative hyponatraemia and postoperative 
hyponatraemia was not demonstrated.[1] This finding is in contrast 
to that reported in the studies by Leung et al.[2,3] The two studies by 
Leung et al.,[2,3] which were analyses of a large, US surgical database, 
found that hyponatraemia and hypernatraemia were associated with 
a 44% higher risk of 30-day postoperative mortality (odds ratio (OR) 
for hyponatraemia 1.44 (95% CI 1.38 - 1.50); OR for hypernatraemia 
1.44 (95% CI 1.33 - 1.56)). The abovementioned studies also found 
preoperative hyponatraemia/hypernatraemia to be associated with a 
higher risk of postoperative cardiac complications, wound infection, 
pneumonia, extended postoperative length of stay and thrombo-
embolism in patients undergoing major surgical procedures. This 
may suggest a potential geographical variation in the importance of 
preoperative sodium levels between US and European settings. 
Klinck et al.[6] propose a relationship between dysnatraemia 
and underlying neuroendocrine or inflammatory disorders. As 
neuroendocrine and inflammatory disorders are often related to 
the indication for surgery, or are present as comorbid conditions 
in surgical patients, these patients might be at risk of developing 
dysnatraemia. These authors investigated the clinical correlation 
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of large perioperative sodium changes. A decrease in sodium 
concentration was associated with older patients (>60 years) and 
those who had undergone procedures of longer duration. Those 
with diabetes or liver disease who were mechanically ventilated 
or receiving oxygen, and who used patient-controlled analgesia in 
the postoperative period, were more likely to have a large decrease 
in sodium than those who did not receive such analgesia. Major 
urological and renal procedures were also associated with this 
risk compared with a reference group comprising all inpatient 
laparoscopic operations. Obesity appeared to be protective against 
large decreases.[6]
While there is literature describing the potential prognostic 
importance of preoperative serum sodium levels in overseas surgical 
populations, the importance of preoperative serum sodium levels 
in South African (SA) surgical patients is poorly described.[1-3,6] 
As discordances in the importance of other preoperative clinical 
risk factors for inpatient mortality between SA and other surgical 
populations have been previously described, it is necessary to 
establish the clinical significance of abnormal preoperative serum 
sodium measurements on postoperative outcomes in SA surgical 
patients and not extrapolate its clinical significance from studies 
in other settings.[7] This is made even more pertinent as there have 
already been differences identified in the clinical importance of 
hyponatraemia between US and European settings. Establishing the 
clinical importance of preoperative sodium levels in a SA setting 
would have implications as to whether these measurements should 
be included as a variable of interest during the future development of 
setting-specific perioperative risk stratification methods.
Objective
The objective of this study was to determine whether preoperative 
serum sodium measurements are associated with postoperative 
inpatient mortality in SA surgical patients.
Methods
Study design and setting
This was an unmatched case-control study of data collected as part 
of the South African Surgical Outcomes Study (SASOS). SASOS 
was a snapshot audit of surgical patients attending SA government 
hospitals during a 1-week period in 2014.[8] 
Patients, data and sample size
The SASOS database is comprised of 3 927 SA patients ≥16 years old, 
who underwent surgical procedures at 45 government hospitals between 
19 and 26 May 2014. Various patient and clinical characteristics were 
collected during SASOS, including patient age, gender, comorbidities, 
preoperative laboratory test results (including serum sodium 
measurements), procedure data, and data related to postoperative 
inpatient mortality. Patients were classified as white and black, with 
black being inclusive of any patient who is of African, Indian or 
Coloured ethnicity. All laboratory tests were performed within 28 days 
before surgery.[8]
The definitions for hyponatraemia and hypernatraemia used 
in this study were adopted from the published literature (hypo-
natraemia: <135 mEq/L, hypernatraemia: >144 mEq/L, normal: 135 - 
 144 mEq/L).[1-3] A case was defined as a patient who suffered inpatient 
mortality, while a control was defined as a patient who did not suffer 
inpatient mortality. Sample size calculations suggested that a study 
population of 513 patients (using a conventional 1:4 ratio of cases to 
controls in unmatched case-control studies (103 cases and 410 controls)) 
would be required for this research. Following exclusion of patients 
with missing data, cases and controls were randomly selected using 
a random number generator from the SASOS patient population 
until the specified sample size was attained. This was done to reduce 
selection bias, in accordance with published guidelines for the 
conduct of unmatched case-control studies.[9,10] 
Data analysis
We followed published recommendations for the statistical analysis of 
unmatched case-control study data.[9,10] To investigate the relationship 
between preoperative serum sodium and postoperative inpatient 
mortality, patient data were analysed using univariate/crude (χ2 test, 
Fisher’s exact test for categorical data or the Mann-Whitney test for 
continuous data) and multivariate/adjusted (unconditional logistic 
regression model) statistical methods. Results for the univariate 
statistical analysis are presented as frequencies with percentages, or 
medians with interquartile ranges (IQRs). Potential confounders 
identified from the univariate statistical analysis were accounted 
for in the unconditional logistic regression model. Results for the 
multivariate analysis are presented as ORs and 95% CIs. A p-value <0.05 
was considered to be statistically significant. All statistical analyses 
were performed using SPSS version 24.0 (IBM Corp., USA). 
Ethical approval
This study was approved by the Biomedical Research Ethics 
Committee of the University of KwaZulu-Natal, Durban, SA (ref. no. 
BE437/17). 
Results
Table 1 shows the distribution of patient and clinical characteristics in 
the entire study population (N=513), as well as the study population 
stratified into case and control groups (n=103 and n=410, respectively). 
The median age of the study population was 46.0 (31.5 - 60.0) years; it 
comprised more males than females. Nine in every 10 patients were 
black. A third of patients had severe systemic disease (American 
Society of Anesthesiologists (ASA) score >2), while a quarter were 
current smokers. The prevalence of various comorbidities ranged 
between 0.6% and 56.3%. Just over three-quarters of the study 
population had normal preoperative serum sodium measurements 
(77.8%), with preoperative dysnatraemia present in the remaining 
22.2% (18.5% with hyponatraemia and 3.7% with hypernatraemia). 
Non-communicable disease pathology was the primary indication 
for surgery in almost half of the study population. Just over half of 
surgical procedures performed were urgent/emergent, with almost 
three-quarters undergoing major surgery. General anaesthesia was 
used in the majority of surgical procedures. 
The univariate/crude statistical associations between various 
patient/clinical characteristics and postoperative inpatient mortality 
are shown in Table 1. Statistically significant associations with 
postoperative inpatient mortality were noted for age (p<0.001), ASA 
score >2 (p<0.001), metastatic cancer (p<0.001), HIV (p=0.032), renal 
impairment (p<0.001), preoperative anaemia (p<0.001), preoperative 
serum sodium measurements (p<0.001), urgent/emergent surgery 
(p<0.001) and major surgery (p<0.001). Specifically, the median age 
of the case group was higher than that of the control group (56.0 
v. 43.0 years, respectively); a higher proportion of cases v. controls 
had an ASA score >2 (69.9% v. 23.9%), metastatic cancer (11.7% v. 
2.4%), renal impairment (14.6% v. 2.9%), urgent/emergent surgery 
(76.9% v. 49.3%) and major surgery (45.6% v. 22.4%). With regard 
to preoperative serum sodium measurements, the case group had a 
higher proportion of hyponatraemia and hypernatraemia compared 
with the control group (26.2% v. 16.5%, and 10.7% v. 2.0%).  
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Table 1. Distribution of patient/clinical characteristics in the study population and results of the univariate statistical analysis*
Clinical characteristic All patients (N=513) Cases (n=103) Controls (n=410) p-value†
Age, years (IQR) 46.0 (31.5 - 60.0) 56.0 (39.0 - 65.0) 43.0 (30.0 - 58.0) <0.001
Gender 0.793
Male 273 (53.2) 56 (54.4) 217 (52.9)
Female 240 (46.8) 47 (45.6) 193 (47.1)
Race 0.733
White 55 (10.7) 12 (11.7) 43 (10.5)
Black 458 (89.3) 91 (88.3) 367 (89.5)
ASA score >2 <0.001
Yes 170 (33.1) 72 (69.9) 98 (23.9)
No 343 (66.9) 31 (30.1) 312 (76.1)
Current smoker 0.201
Yes 135 (26.3) 22 (21.4) 113 (27.6)
No 378 (73.7) 81 (78.6) 297 (72.4)
Cardiovascular disease 0.438
Yes 54 (10.5) 13 (12.6) 41 (10.0)
No 459 (89.5) 90 (87.4) 369 (90.0)
Metastatic cancer <0.001
Yes 22 (4.3) 12 (11.7) 10 (2.4)
No 491 (95.7) 91 (88.3) 400 (97.6)
Cirrhosis 0.490
Yes 3 (0.6) 1 (1.0) 2 (0.5)
No 510 (99.4) 102 (99.0) 408 (99.5)
Chronic obstructive pulmonary disease 0.808
Yes 37 (7.2) 8 (7.8) 29 (7.1)
No 476 (92.8) 95 (92.2) 381 (92.9)
HIV 0.032
Yes 80 (15.6) 9 (8.7) 71 (17.3)
No 433 (84.4) 94 (91.3) 339 (82.7)
Diabetes 0.277
Yes 68 (13.3) 17 (16.5) 51 (12.4)
No 445 (86.7) 86 (83.5) 359 (87.6)
Renal impairment <0.001
Yes 27 (5.3) 15 (14.6) 12 (2.9)
No 486 (94.7) 88 (85.4) 398 (97.1)
Preoperative anaemia <0.001
Yes 262 (51.1) 74 (71.8) 188 (45.9)
No 251 (48.9) 29 (28.2) 222 (54.1)
Other comorbidity not otherwise specified‡ 0.181
Yes 289 (56.3) 52 (50.5) 237 (57.8)
No 224 (43.7) 51 (49.5) 173 (42.2)
Preoperative sodium measurement <0.001
Hyponatraemia 95 (18.5) 27 (26.2) 68 (16.5)
Hypernatraemia 19 (3.7) 11 (10.7) 8 (2.0)
Normal 399 (77.8) 65 (63.1) 334 (81.5)
Indication for surgery 0.302
Non-communicable disease 240 (46.8) 43 (41.7) 197 (48.0)
Injury/trauma 161 (31.4) 32 (31.1) 129 (31.5)
Infectious disease 112 (21.8) 28 (27.2) 84 (20.5)
Urgent/emergent surgery <0.001
Yes 284 (55.4) 82 (79.6) 202 (49.3)
No 229 (44.6) 21 (20.4) 208 (50.7)
Major surgery <0.001
Yes 139 (27.1) 47 (45.6) 92 (22.4)
No 374 (72.9) 56 (54.4) 318 (77.6)
Surgery with general anaesthesia 0.093
Yes 364 (71.0) 80 (77.7) 284 (69.3)
No 149 (29.0) 23 (22.3) 126 (30.7)
IQR = interquartile range; ASA = American Society of Anesthesiologists.
*Results expressed as frequencies (%) or medians (IQR). 
†Univariate/unadjusted p-value for comparisons between case and control groups.
‡As per variable used in the South African Surgical Outcomes Study (SASOS). 
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Table 2. Results of the multivariate statistical analysis
Clinical characteristic OR (95% CI) p-value*
Age (per year increase) 1.04 (1.02 - 1.06) <0.001
Gender
Male 0.83 (0.46 - 1.51) 0.541
Female Reference -
Race
White 0.44 (0.18 - 1.10) 0.078
Black Reference -
ASA score >2
Yes 5.00 (2.64 - 9.45) <0.001
No Reference -
Current smoker
Yes 0.89 (0.45 - 1.75) 0.730
No Reference -
Cardiovascular disease
Yes 0.34 (0.10 - 1.14) 0.079
No Reference -
Metastatic cancer
Yes 2.13 (0.53 - 8.58) 0.288
No Reference -
Cirrhosis
Yes 0.99 (0.05 - 18.16) 0.993
No Reference -
Chronic obstructive pulmonary disease
Yes 0.51 (0.14 - 1.80) 0.292
No Reference -
HIV
Yes 0.31 (0.07 - 1.30) 0.109
No Reference -
Diabetes 
Yes 0.47 (0.13 - 1.66) 0.242
No Reference -
Renal impairment
Yes 3.22 (1.14 - 9.08) 0.027
No Reference -
Preoperative anaemia
Yes 1.72 (0.94 - 3.14) 0.078
No Reference -
Other comorbidity not otherwise specified†
Yes 0.83 (0.22 - 3.06) 0.777
No Reference -
Preoperative sodium measurement
Hyponatraemia 1.39 (0.70 - 2.76) 0.346
Hypernatraemia 4.21 (1.19 - 14.83) 0.025
Normal Reference -
Indication for surgery
Non-communicable disease 0.99 (0.47 - 2.09) 0.976
Injury/trauma 1.35 (0.61 - 2.98) 0.458
Infectious disease Reference -
Urgent/emergent surgery
Yes 3.57 (1.88 - 6.80) <0.001
No Reference -
Major surgery
Yes 2.69 (1.42 - 5.06) 0.002
No Reference -
Surgery with general anaesthesia
Yes 2.11 (1.03 - 4.33) 0.041
No Reference -
IQR= interquartile range; ASA = American Society of Anesthesiologists; OR = odds ratio; CI = confidence interval.
*Multivariate/adjusted p-value from comparisons between case and control groups.
†As per variable used in the South African Surgical Outcomes Study (SASOS).
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The results of the multivariate/adjusted statistical analysis are shown 
in Table 2. Patients with preoperative hypernatraemia, but not pre-
operative hyponatraemia, were found to have a higher risk of post-
operative inpatient mortality compared with those who had normal 
preoperative serum sodium measurements (OR 4.21, 95% CI 1.19 
- 14.83, p=0.025 for hypernatraemia; OR 1.39, 95% CI 0.70.0 - 2.76, 
p=0.346 for hyponatraemia). Other patient/clinical characteristics 
independently associated with a higher risk of postoperative inpa-
tient mortality were: increasing age (OR 1.04, 95% CI 1.02 - 1.06, 
p<0.001), ASA score >2 (OR 5.00, 95% CI 2.64 - 9.45, p<0.001), renal 
impairment (OR 3.22, 95% CI 1.14 - 9.08, p=0.027), urgent/emergent 
surgery (OR 3.57, 95% CI 1.88 - 6.80, p<0.001), major surgery 
(OR 2.69, 95% CI 1.42 - 5.06, p=0.002), and general anaesthesia 
(OR 2.11, 95% CI 1.03 - 4.33, p=0.041). 
Discussion
The crude statistical association reported between preoperative 
serum sodium measurements and postoperative inpatient mortality 
in our univariate statistical analysis translated into a statistically 
significant, independent association when potential confounders 
were accounted for. Specifically, preoperative hypernatraemia was 
associated with a four-fold higher risk of postoperative inpatient 
mortality compared with preoperative serum sodium measurements 
within the normal range. Preoperative hyponatraemia was not 
independently associated with postoperative inpatient mortality 
compared with preoperative serum sodium measurements 
within the normal range. In a subanalysis of data from EuSOS, 
preoperative hypernatraemia was independently associated with a 1.3 
- 3.4-fold higher risk of postoperative mortality, while preoperative 
hyponatraemia was not identified as a risk factor for postoperative 
inpatient mortality.[1] In the two studies by Leung et al.,[2,3] patients with 
preoperative hyponatraemia or preoperative hypernatraemia had a 
44% higher risk of postoperative mortality compared with those with 
normal preoperative serum sodium measurements.
The similarity of our study findings to those of a European cohort 
(EuSOS) and one of the US studies by Leung et al.[2] suggests that 
preoperative hypernatraemia is a potentially important prognostic 
variable in both lower/middle-income and higher-income countries. 
While we did not observe increased mortality in patients with 
preoperative hyponatraemia, which was reported in one of the studies 
by Leung et al.,[3] our finding for hyponatraemia is similar to that 
reported in the EuSOS sub-study. Cecconi et al.[1] provided a possible 
explanation for the discordant findings between their subanalysis 
of the EuSOS data and the study of Leung et al.,[2] suggesting that 
the EuSOS prospective design and extensive data collection during 
the study period had allowed them better control for potential 
confounders in their multivariate analysis than was possible in the 
study of Leung et al. As the design and conduct of SASOS were based 
on those of EuSOS, it is likely that the explanation for the discordancy 
in study findings for hyponatraemia between our and Leung et al.’s 
studies is the same as that proposed by Cecconi et al.[1] 
Our study findings, as well as the relatively cheap cost and 
availability of serum sodium measurements performed at diagnostic 
laboratories or as point-of-care tests, raise interest in the possibility 
of using preoperative serum sodium measurements for prognostic 
purposes in resource-limited settings. Further research investigating 
the prognostic accuracy of preoperative serum sodium measurements 
in resource-limited settings is recommended. 
While we present findings related to other patient/clinical 
characteristics, we advise caution when interpreting these findings, 
as our unmatched case-control study was specifically designed to 
determine the relationship between preoperative serum sodium 
measurements and postoperative inpatient mortality. The other 
patient/clinical characteristics were included in the multivariate 
statistical analysis as a method to control for potential confounders, 
according to recommendations for unmatched case-control studies.[9,10] 
A broad investigation of the potential impact of these patient/clinical 
characteristics on postoperative inpatient mortality has already been 
described as a component of the main SASOS publication, and more 
specific investigations would require additional case-control studies 
to be performed.[8] 
Study strengths and limitations
A strength of our study is that we present a subanalysis of prospectively 
collected data from a large, representative study of perioperative 
outcomes in SA surgical patients. An important limitation of our 
study is that there might be some potentially relevant patient/clinical 
characteristics (such as medication use) that were not recorded 
during the data collection phase of SASOS. Therefore, we could not 
control for any confounding attributed to these characteristics in our 
multivariate statistical analysis. The cause of inpatient mortality was 
also not recorded as part of SASOS, and therefore all-cause inpatient 
mortality is reported in our study. As the SASOS design was based 
on that of EuSOS, we also acknowledge that our study has additional 
limitations similar to those reported by Cecconi et al.[1] Further 
prospective research is required to confirm our findings and address 
the limitations of our study.
Conclusions
Preoperative hypernatraemia was found to be an important risk factor 
for postoperative mortality in SA surgical patients. Hyponatraemia 
was not found to be a risk factor for postoperative mortality in our 
study. Further research is required to assess the prognostic accuracy 
of preoperative serum sodium measurements in SA surgical patients, 
as well as to address the limitations of our study.
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